Watchdog calls on federal officials to advance the HHS deprescribing plan with strong patient protections, as psychiatry attempts to weaken antidepressant tapering reforms

Watchdog's decades-long advocacy for patient rights and safe psychotropic withdrawal gains powerful validation amid rising debate on psychiatric drug risks

New laws highlight Tennessee's proactive response to growing concerns over psychiatric drug risks and potential links to violence. CCHR says these reforms are needed nationwide

New federal actions emphasize informed consent, holistic care, and protection for children and adults from psychiatric drug risks—but broader access to deprescribing support remains essential